{"id":"https://genegraph.clinicalgenome.org/r/97f10614-b0ad-428f-a13c-c867f31a552ev1.1","type":"EvidenceStrengthAssertion","dc:description":"EIF2B5 was first associated with autosomal recessive leukoencephalopathy with vanishing white matter in 2001 (Leegwater et al., PMID: 11704758). Affected individuals present with gait dysfunction, spasticity, cognitive decline, and white matter abnormalities on MRI.  Some individuals develop ovarian failure. Onset is variable from infancy to adulthood, and progression of disease is often in the setting of fever, trauma, or stress. Vanishing white matter disease has also been referred to as Childhood Ataxia with Central Nervous System Hypomyelination (CACH) and Cree leukoencephalopathy. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found that a phenotypic spectrum exists and there is no difference in molecular mechanism or inheritance pattern. Therefore, we chose to curate this gene-disease relationship under the disease term leukoencephalopathy with vanishing white matter 5 (OMIM:603945, MONDO:0957873). \n\nTwelve variants (missense, nonsense) that have been reported in 8 probands in 5 publications (PMIDs: 19158808, 15136673, 21484434 30014503, 17646634) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is reported to be loss of function. This gene-disease relationship is also supported by experimental evidence, (PMIDs: 33300869, 20826436). The mouse model of EIF2B5 related leukoencephalopathy exhibits motor deficits, myelin degeneration, abnormal density of oligodendrocytes and astrocytes, and increased sensitivity to brain insult, which recapitulates the human disease. The zebrafish model is associated with impaired motor behavior and myelin defects.  In summary, definitive evidence supports the relationship between EIF2B5 and leukoencephalopathy with vanishing white matter 5. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Leukodystrophy and Leukoencephalopathy GCEP on the meeting date July 22, 2024 (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/97f10614-b0ad-428f-a13c-c867f31a552e","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d6cf3226-04b0-4709-bc55-b97ca4bea8d7","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:sopChange"},{"id":"cg:summaryChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d6cf3226-04b0-4709-bc55-b97ca4bea8d7_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2024-12-12T00:45:12.495Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/d6cf3226-04b0-4709-bc55-b97ca4bea8d7_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2024-12-11T17:00:00.000Z","role":"Approver"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6cf3226-04b0-4709-bc55-b97ca4bea8d7_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc47a461-711b-4351-8ad4-0826c734395b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc47a461-711b-4351-8ad4-0826c734395b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30014503","rdfs:label":"Hamilton Patient 2","allele":[{"id":"https://genegraph.clinicalgenome.org/r/1fc8b952-caad-4333-9640-06fc574561ff","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003907.3(EIF2B5):c.1015C>T (p.Arg339Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2726569"}},{"id":"https://genegraph.clinicalgenome.org/r/8cd82862-7dbd-4505-9bd9-a5222045c46a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003907.3(EIF2B5):c.271A>G (p.Thr91Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340473"}}],"phenotypeFreeText":"unable to ambulate without support","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/a627feba-733a-43fb-b6c5-3aa1b72c9fff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30014503","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fc8b952-caad-4333-9640-06fc574561ff"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/9649ea51-5cf6-430f-9011-90aa0276dcf6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30014503","allele":{"id":"https://genegraph.clinicalgenome.org/r/8cd82862-7dbd-4505-9bd9-a5222045c46a"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/a627feba-733a-43fb-b6c5-3aa1b72c9fff","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a627feba-733a-43fb-b6c5-3aa1b72c9fff_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/9649ea51-5cf6-430f-9011-90aa0276dcf6","type":"EvidenceLine","dc:description":"Recurrent Variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9649ea51-5cf6-430f-9011-90aa0276dcf6_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/41370dc2-c2eb-4021-9d7b-98c90a1c4e3d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41370dc2-c2eb-4021-9d7b-98c90a1c4e3d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30014503","rdfs:label":"Hamilton Patient 1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/8cd82862-7dbd-4505-9bd9-a5222045c46a"},{"id":"https://genegraph.clinicalgenome.org/r/1fc8b952-caad-4333-9640-06fc574561ff"}],"phenotypeFreeText":"unable to ambulate without support","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/10f516c0-98a2-4d0f-894a-885ee1dd1c69_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30014503","allele":{"id":"https://genegraph.clinicalgenome.org/r/8cd82862-7dbd-4505-9bd9-a5222045c46a"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/0af1334d-ef64-4831-90e1-984c424558c0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30014503","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fc8b952-caad-4333-9640-06fc574561ff"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/0af1334d-ef64-4831-90e1-984c424558c0","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0af1334d-ef64-4831-90e1-984c424558c0_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/10f516c0-98a2-4d0f-894a-885ee1dd1c69","type":"EvidenceLine","dc:description":"Recurrent Variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10f516c0-98a2-4d0f-894a-885ee1dd1c69_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/09b3bc7b-30f4-4ea9-9640-2502b6206503_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/09b3bc7b-30f4-4ea9-9640-2502b6206503","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","rdfs:label":"Individual 435","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/44ec5405-9b93-438a-8857-bbf8fa945977","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003907.3(EIF2B5):c.338G>A (p.Arg113His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117878"}},{"id":"https://genegraph.clinicalgenome.org/r/03ac207b-b625-49f6-af5a-f78a14b15ab9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003907.3(EIF2B5):c.1264C>T (p.Arg422Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA88843349"}}],"firstTestingMethod":"PCR","phenotypeFreeText":"motor signs; diffuse cavitation on MRI","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/5b348549-f1f1-4e74-85e1-6be47e31c130_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/44ec5405-9b93-438a-8857-bbf8fa945977"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/aaf9266b-9afc-4efc-ba5e-2dd39f191927_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/03ac207b-b625-49f6-af5a-f78a14b15ab9"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/5b348549-f1f1-4e74-85e1-6be47e31c130","type":"EvidenceLine","dc:description":"Recurrent Variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b348549-f1f1-4e74-85e1-6be47e31c130_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/aaf9266b-9afc-4efc-ba5e-2dd39f191927","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aaf9266b-9afc-4efc-ba5e-2dd39f191927_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/2315a9b1-e48b-4980-8f43-3da189c2c71c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2315a9b1-e48b-4980-8f43-3da189c2c71c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17646634","rdfs:label":"Patient 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":10,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/ca38ca7b-6e22-4100-bb36-0d2cf42c5d1c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003907.3(EIF2B5):c.944G>A (p.Arg315His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340481"}},{"id":"https://genegraph.clinicalgenome.org/r/1552cce5-d4d4-41fe-bcc7-0c4c2d3e2ba6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003907.3(EIF2B5):c.166T>G (p.Phe56Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340482"}}],"phenotypeFreeText":"History of two acute episodes of neurologic deterioration during viral infections at ages 10 and 14 months, followed by a progressive decline. Brain MRI showed severe white matter abnormalities.  Neuropathologic analysis showed an increased oligodendrocyte density but no Rosenthal fibers. Head circumference (HC) reached 58 cm, and she passed at age 8.5.","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b126c895-d119-49f7-ba84-50187b0c529e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17646634","allele":{"id":"https://genegraph.clinicalgenome.org/r/1552cce5-d4d4-41fe-bcc7-0c4c2d3e2ba6"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/c7c99a18-d993-4a07-8eb0-fc2949e60139_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17646634","allele":{"id":"https://genegraph.clinicalgenome.org/r/ca38ca7b-6e22-4100-bb36-0d2cf42c5d1c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/b126c895-d119-49f7-ba84-50187b0c529e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b126c895-d119-49f7-ba84-50187b0c529e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/b126c895-d119-49f7-ba84-50187b0c529e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Guanine nucleotide exchange factor (GEF) activity of eIF2B measured in lymphoblasts had decreased to the range found in severe infantile forms. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c7c99a18-d993-4a07-8eb0-fc2949e60139","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7c99a18-d993-4a07-8eb0-fc2949e60139_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c7c99a18-d993-4a07-8eb0-fc2949e60139_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Guanine nucleotide exchange factor (GEF) activity of eIF2B measured in lymphoblasts had decreased to the range found in severe infantile forms. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/7b040c6e-ba2d-4d45-bff0-40bdfe1309d7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b040c6e-ba2d-4d45-bff0-40bdfe1309d7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19158808","rdfs:label":"Wu Patient 3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/03b25318-4e6d-40d1-b62f-91bfc652178a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003907.3(EIF2B5):c.1004G>C (p.Cys335Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA355385682"}},{"id":"https://genegraph.clinicalgenome.org/r/2615445c-6606-4e75-b213-0b97f4291127","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003907.3(EIF2B5):c.805C>T (p.Arg269Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA355383452"}}],"firstTestingMethod":"PCR","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d7eb019a-00f8-48c0-8707-324f7d654bf8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19158808","allele":{"id":"https://genegraph.clinicalgenome.org/r/2615445c-6606-4e75-b213-0b97f4291127"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/02f73720-5d19-429d-b2f8-11cab19dd8c7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19158808","allele":{"id":"https://genegraph.clinicalgenome.org/r/03b25318-4e6d-40d1-b62f-91bfc652178a"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/02f73720-5d19-429d-b2f8-11cab19dd8c7","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02f73720-5d19-429d-b2f8-11cab19dd8c7_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d7eb019a-00f8-48c0-8707-324f7d654bf8","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7eb019a-00f8-48c0-8707-324f7d654bf8_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/f8c29cbb-e172-494c-b13f-3c400db80ac8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8c29cbb-e172-494c-b13f-3c400db80ac8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","rdfs:label":"Individual 431","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/44ec5405-9b93-438a-8857-bbf8fa945977"},{"id":"https://genegraph.clinicalgenome.org/r/048ef268-bb5e-4355-bb66-0e594708a9bd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003907.3(EIF2B5):c.1884G>A (p.Trp628Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA88844128"}}],"firstTestingMethod":"PCR","phenotypeFreeText":"motor signs,; diffuse cavitation of the white matter","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e58db378-616c-4c4d-b74a-6f357206be08_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/048ef268-bb5e-4355-bb66-0e594708a9bd"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/b424dded-dda5-4b12-982e-c33b6f2cd96e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/44ec5405-9b93-438a-8857-bbf8fa945977"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/b424dded-dda5-4b12-982e-c33b6f2cd96e","type":"EvidenceLine","dc:description":"Recurrent Variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b424dded-dda5-4b12-982e-c33b6f2cd96e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e58db378-616c-4c4d-b74a-6f357206be08","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e58db378-616c-4c4d-b74a-6f357206be08_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/55b496a0-3614-478f-8944-31ab5a748e5f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55b496a0-3614-478f-8944-31ab5a748e5f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","rdfs:label":"Individual 1036","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":9,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/f76312d5-b10b-4155-88e3-900ae68328c8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003907.3(EIF2B5):c.1280C>T (p.Pro427Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2726631"}},{"id":"https://genegraph.clinicalgenome.org/r/2280afaa-c5c6-433a-ae61-83d9cd085795","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003907.3(EIF2B5):c.967C>T (p.Pro323Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA88842884"}}],"firstTestingMethod":"PCR","phenotypeFreeText":"delay in motor development in the first 2 years of age; motor signs potentially coupled with acute episode; diffuse cavitation of the white matter","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/a77745b3-fb6a-4d67-b609-ef0129212e68_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/2280afaa-c5c6-433a-ae61-83d9cd085795"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/bfc1aa00-f042-4374-9e8f-f4536628420a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/f76312d5-b10b-4155-88e3-900ae68328c8"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/bfc1aa00-f042-4374-9e8f-f4536628420a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bfc1aa00-f042-4374-9e8f-f4536628420a_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a77745b3-fb6a-4d67-b609-ef0129212e68","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a77745b3-fb6a-4d67-b609-ef0129212e68_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/0b36ba33-176b-4f6a-91c8-96225cb5d1e7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b36ba33-176b-4f6a-91c8-96225cb5d1e7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21484434","rdfs:label":"Case 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7042510-add0-43ae-bfbe-fa7573b3d99e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003907.3(EIF2B5):c.808G>C (p.Asp270His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343821"}},"phenotypeFreeText":"adult onset; progressive gait disturbance, sometimes in a phased manner after a minor trauma.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cf03cb6c-5e4b-4a6f-9603-e2d2a243043b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21484434","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7042510-add0-43ae-bfbe-fa7573b3d99e"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/cf03cb6c-5e4b-4a6f-9603-e2d2a243043b","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf03cb6c-5e4b-4a6f-9603-e2d2a243043b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/cf03cb6c-5e4b-4a6f-9603-e2d2a243043b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Analyzed activities of eIF2B GEF-containing mutant EIF2B subunits. The GDP/GTP exchange activities of eIF2B containing the mutant eIF2Bε (Asp270His) subunit substantially and significantly decreased compared with that of eIF2B containing WT eIF2Bε (Fig. 1e).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":9},{"id":"https://genegraph.clinicalgenome.org/r/d6cf3226-04b0-4709-bc55-b97ca4bea8d7_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6cf3226-04b0-4709-bc55-b97ca4bea8d7_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c49681a4-9410-4adb-8096-3f660a9b40d4","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eabc2d4d-d4e1-4cef-b09d-c47f2f08a384","type":"Finding","dc:description":"Similar to patients with EIF2B5-related Leukodystrophy, mouse model exhibits motor deficits, \nmyelin degeneration, abnormal density of oligodendrocytes and astrocytes, and increased sensitivity to brain insult.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20826436","rdfs:label":"Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3ed639cb-3cd8-4098-abe6-f86c3b6a4558","type":"EvidenceLine","dc:description":"Non-mammalian model","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a996e154-3659-4ad7-b3bb-5f7b2b183f91","type":"Finding","dc:description":"Patients with EIF2B5-related Leukodystrophy have a loss of white matter and abnormal white matter signal quality on MRI. Likewise, mutant zebrafish show abnormal myelination defects. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33300869","rdfs:label":"Zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Definitive","sequence":9507,"specifiedBy":"GeneValidityCriteria11","strengthScore":12,"subject":{"id":"https://genegraph.clinicalgenome.org/r/-PRWPjsgXMU","type":"GeneValidityProposition","disease":"obo:MONDO_0957873","gene":"hgnc:3261","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d6cf3226-04b0-4709-bc55-b97ca4bea8d7-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}